Initial experience of a nephrologist-operated vascular access center

被引:13
作者
Jackson, JW [1 ]
Lewis, JL [1 ]
Brouillette, JR [1 ]
Brantley, RR [1 ]
机构
[1] Nephrol Associates PC, Birmingham, AL 35211 USA
关键词
D O I
10.1046/j.1525-139x.2000.00099.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
A nephrology practice in Alabama did not feel in control of vascular access management. Scheduling delays, as well as variable techniques and outcomes, leading to high morbidity and mortality, caused frustration with the existing care system for vascular access. Our objective was to develop an integrative system of vascular access care, involving nephrologists along with the other caregivers, and to demonstrate an improvement in outcomes. Nephrology Vascular Labs (NVL), a recent RMS-Lifeline acquisition, opened a vascular access center (VAC) as an extension of the nephrology practice. Both pre-ESRD and ESRD patients are evaluated and treated in the VAC. Treatment is rendered in a timely fashion, to the benefit of the patients. Nephrologists serve as the interventionists. More than 90% of vascular access problems detected at dialysis are treated at the VAC. More than 2000 procedures have been performed over 2 years. Procedures carried out include thrombolysis with angioplasty, fluoroscopy alone or with angioplasty, placement of cuffed and noncuffed catheters, removal of cuffed catheters, and minor surgeries. Success rates have been high. Minor and major complications have been relatively low. Referrals to both surgeons and radiologists are shown to emphasize the role of the VAC as part of an integrative system of vascular access care. Results of a patient satisfaction survey were excellent. The VAC has fulfilled the vision of creating a seamless integration of care for vascular access. Hospitalization rate has been reduced and it is suspected that the global cost of access care is markedly lower than prior to the VAC. Multiple nephrologists can rotate as the VAC's interventionist and jointly obtain good outcomes and have little variability among them. Several reasons for using a nephrologists as the interventionist are discussed.
引用
收藏
页码:354 / 358
页数:5
相关论文
共 14 条
[1]   MECHANICAL VERSUS PHARMACOMECHANICAL THROMBOLYSIS FOR THE TREATMENT OF THROMBOSED DIALYSIS ACCESS GRAFTS [J].
BEATHARD, GA .
KIDNEY INTERNATIONAL, 1994, 45 (05) :1401-1406
[2]   PERCUTANEOUS ANGIOPLASTY FOR THE TREATMENT OF VENOUS STENOSIS - A NEPHROLOGISTS VIEW [J].
BEATHARD, GA .
SEMINARS IN DIALYSIS, 1995, 8 (03) :166-170
[3]  
COOPER GC, 1996, SEMIN DIALYSIS, V9, pS37
[4]  
COOPER SG, 1996, SEMIN DIALYSIS, V9, pS33
[5]   HEMODIALYSIS VASCULAR ACCESS MORBIDITY IN THE UNITED-STATES [J].
FELDMAN, HI ;
HELD, PJ ;
HUTCHINSON, JT ;
STOIBER, E ;
HARTIGAN, MF ;
BERLIN, JA .
KIDNEY INTERNATIONAL, 1993, 43 (05) :1091-1096
[6]   Hemodialysis access failure: A call to action [J].
Hakim, R ;
Himmelfarb, J .
KIDNEY INTERNATIONAL, 1998, 54 (04) :1029-1040
[7]  
Hirth RA, 1996, JAMA-J AM MED ASSOC, V276, P1303
[8]   Prospective randomized comparison of surgical versus endovascular management of thrombosed dialysis access grafts [J].
Marston, WA ;
Criado, E ;
Jaques, PF ;
Mauro, MA ;
Burnham, SJ ;
Keagy, BA .
JOURNAL OF VASCULAR SURGERY, 1997, 26 (03) :373-380
[9]  
Marston WA, 1998, AM J KIDNEY DIS, V32, P168
[10]  
*NKF DOQI, 1997, CLIN PRACT GUID VASC